An educational introduction to peptides for healthcare professionals — what they are, how they are being studied, and how providers can explore peptide therapies within the ALML portfolio.
Peptides are short chains of amino acids that occur naturally in the body and are being studied for a range of potential roles in cellular signaling, recovery, and metabolic processes.
Much of the current understanding comes from preclinical and emerging clinical research. Healthcare professionals should independently evaluate the available evidence before considering use.
Peptide therapies explored through ALML are intended for provider-directed programs. Treatment and prescribing decisions remain the responsibility of the licensed healthcare professional.
Many peptides are investigational and not FDA-approved for the treatment, cure, or prevention of disease. ALML provides educational information and does not replace independent clinical judgment.
Many peptides are investigational and are not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. Providers should evaluate the evidence and applicable regulations independently.
ALML is built for healthcare practices. Clinics open an account, and ordering is intended for provider-directed programs under the supervision of a licensed healthcare professional.
ALML provides product and educational information for healthcare professionals. Patient-specific dosing and prescribing decisions remain the responsibility of the treating provider.
Browse the full catalog by therapy category and find options for your practice.